Ocugen, Inc. (OCGN) — Insider Activity & Signal

Healthcare · Biotechnology · Market cap $498M · $1.47 · 52-week range $0.93–$2.73

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-06-15	Johnson-Greene Treerita Essalima	officer: Chief Financial Officer	21,000	$1.23	$25,830	SEC Form 4

Financial health

Altman Z-Score -8.05 · Piotroski F-Score 2/9 · Cash $19M · Debt $33M

ClearOcean signal read

ClearOcean's model currently scores OCGN as a watchlist-level signal (5/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — OCGN Form 4
How ClearOcean reads insider activity

Last updated July 12, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.